Bußgelder für nicht konforme Formeln (CMR-Stoffe)
Definition
Formula development and stability testing must verify compliance with new bans on 21 CMR substances effective 1 Sep 2025. Failure results in immediate withdrawal, recalls, and enforcement actions by authorities.[1][2][3]
Key Findings
- Financial Impact: €10,000-€100,000 fines per violation + €50,000+ recall costs per batch
- Frequency: Per non-compliant product launch, effective 1 Sep 2025
- Root Cause: Manual stability testing and formula checks missing updated CMR bans in Annex II
Why This Matters
This pain point represents a significant opportunity for B2B solutions targeting Personal Care Product Manufacturing.
Affected Stakeholders
Formulierer, Qualitätsmanager, Responsible Person (RP)
Deep Analysis (Premium)
Financial Impact
Financial data and detailed analysis available with full access. Unlock to see exact figures, evidence sources, and actionable insights.
Current Workarounds
Financial data and detailed analysis available with full access. Unlock to see exact figures, evidence sources, and actionable insights.
Get Solutions for This Problem
Full report with actionable solutions
- Solutions for this specific pain
- Solutions for all 15 industry pains
- Where to find first clients
- Pricing & launch costs
Methodology & Sources
Data collected via OSINT from regulatory filings, industry audits, and verified case studies.
Related Business Risks
Kosten für CPSR-Nacharbeiten und Stabilitätsfehler
Überhöhte Kosten für PIF-Archivierung und Stabilitätstests
Kosten der schlechten Qualität durch GMP-Verstöße
Überlaufkosten durch Abfall in Batch-Produktion
Strafen bei GMP-Auditversagen
Kapazitätsverluste durch manuelle Qualitätsprüfungen
Request Deep Analysis
🇩🇪 Be first to access this market's intelligence